Arteriolar Vasodilator [EPC]

Arteriolar Vasodilator [EPC] was reported 78651 times

Drugs of the Arteriolar Vasodilator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 120 0.6704
1 VAGINAL FLATULENCE 155 0.5116
2 ANTACID THERAPY 55 0.4231
3 SLEEP DISORDER THERAPY 79 0.3990
4 APPLICATION SITE ACNE 143 0.2918
5 DANDRUFF 603 0.2724
6 APPENDICOLITH 101 0.2610
7 ANALGESIC THERAPY 80 0.2492
8 APPLICATION SITE DRYNESS 833 0.2451
9 HAIR INJURY 68 0.2290
10 DRUG THERAPY 77 0.2271
11 APPLICATION SITE ULCER 156 0.2203
12 CONGENITAL HIATUS HERNIA 50 0.2193
13 PRESBYACUSIS 64 0.2078
14 ANTICOAGULANT THERAPY 55 0.1937
15 MALIGNANT MELANOMA STAGE 0 39 0.1866
16 HYPERTRICHOSIS 301 0.1623
17 APPLICATION SITE PAPULES 169 0.1593
18 APPLICATION SITE EXFOLIATION 635 0.1540
19 APPLICATION SITE PRURITUS 3039 0.1338
20 PRODUCT FORMULATION ISSUE 827 0.1252
21 APPLICATION SITE IRRITATION 1466 0.1177
22 HAIR TEXTURE ABNORMAL 1550 0.1158
23 APPLICATION SITE SCAB 248 0.1147
24 HAIR GROWTH ABNORMAL 747 0.1078
25 ADVERSE DRUG REACTION 8804 0.0979
26 PLEURAL THICKENING 66 0.0965
27 FEMALE GENITAL TRACT FISTULA 163 0.0954
28 GAIT SPASTIC 32 0.0933
29 TRICHORRHEXIS 259 0.0928
30 OBSTRUCTIVE SLEEP APNOEA SYNDROME 125 0.0857
31 MYOGLOBIN BLOOD INCREASED 121 0.0791
32 APPLICATION SITE PARAESTHESIA 97 0.0744
33 BLOOD MAGNESIUM INCREASED 66 0.0732
34 MULTIPLE DRUG THERAPY 55 0.0729
35 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
36 APPLICATION SITE PAIN 1493 0.0677
37 CHRONIC SINUSITIS 252 0.0671
38 PLEURAL FIBROSIS 67 0.0658
39 RADICULOPATHY 171 0.0648
40 HAIR COLOUR CHANGES 781 0.0627
41 SEDATION COMPLICATION 155 0.0607
42 APPLICATION SITE INFLAMMATION 79 0.0570
43 PROCTITIS 158 0.0563
44 MACULAR DEGENERATION 656 0.0549
45 APPLICATION SITE HYPERSENSITIVITY 65 0.0535
46 DRUG ADMINISTERED AT INAPPROPRIATE SITE 554 0.0525
47 HYPERPHOSPHATAEMIA 110 0.0511
48 SEBORRHOEA 182 0.0495
49 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 45 0.0485
50 CENTRAL SEROUS CHORIORETINOPATHY 32 0.0469
51 HAIR DISORDER 375 0.0455
52 RELAPSING-REMITTING MULTIPLE SCLEROSIS 39 0.0451
53 APPLICATION SITE DISCOMFORT 80 0.0445
54 APPLICATION SITE RASH 607 0.0441
55 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 785 0.0428
56 BRAIN NATRIURETIC PEPTIDE INCREASED 130 0.0421
57 HYPERPARATHYROIDISM SECONDARY 105 0.0419
58 CREATININE RENAL CLEARANCE DECREASED 164 0.0409
59 APPLICATION SITE DISCHARGE 47 0.0407
60 PLANTAR FASCIITIS 130 0.0387
61 BONE CYST 34 0.0362
62 BLOOD PHOSPHORUS INCREASED 99 0.0362
63 PRODUCT CONTAINER ISSUE 307 0.0358
64 APPLICATION SITE WARMTH 45 0.0353
65 WRONG PATIENT RECEIVED MEDICATION 94 0.0344
66 PRODUCT CLOSURE REMOVAL DIFFICULT 35 0.0343
67 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 35 0.0330
68 APPLICATION SITE ERYTHEMA 844 0.0322
69 NEPHROGENIC ANAEMIA 146 0.0315
70 TOTAL LUNG CAPACITY DECREASED 48 0.0300
71 ALOPECIA 5803 0.0295
72 POOR QUALITY PRODUCT ADMINISTERED 303 0.0287
73 EAR SWELLING 54 0.0255
74 DEAFNESS NEUROSENSORY 83 0.0252
75 APPLICATION SITE VESICLES 163 0.0251
76 INFUSION SITE DISCHARGE 44 0.0251
77 APPLICATION SITE HAEMORRHAGE 67 0.0245
78 APPLICATION SITE BURN 120 0.0243
79 OSTEOSCLEROSIS 38 0.0241
80 EYELID PAIN 49 0.0241
81 SKIN WRINKLING 65 0.0239
82 SEBORRHOEIC DERMATITIS 38 0.0230
83 EXPIRED PRODUCT ADMINISTERED 742 0.0223
84 CONTRAINDICATION TO MEDICAL TREATMENT 34 0.0222
85 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 112 0.0221
86 HYPERTONIC BLADDER 60 0.0208
87 ONYCHOCLASIS 138 0.0200
88 TESTICULAR PAIN 63 0.0198
89 IRON DEFICIENCY 89 0.0198
90 ESSENTIAL HYPERTENSION 36 0.0197
91 BLOOD URIC ACID INCREASED 112 0.0194
92 EXOSTOSIS 176 0.0193
93 EPIGASTRIC DISCOMFORT 75 0.0192
94 VAGINAL DISCHARGE 193 0.0191
95 PRODUCT PHYSICAL CONSISTENCY ISSUE 104 0.0188
96 LUNG OPACITY 49 0.0186
97 END STAGE RENAL DISEASE 338 0.0185
98 APPLICATION SITE REACTION 127 0.0180
99 PARAESTHESIA ORAL 260 0.0180
100 INFUSION SITE HAEMORRHAGE 59 0.0179
101 RENAL FUNCTION TEST ABNORMAL 83 0.0179
102 MEDICATION RESIDUE PRESENT 85 0.0178
103 PRE-EXISTING CONDITION IMPROVED 109 0.0174
104 AORTIC STENOSIS 59 0.0169
105 BLOOD CALCIUM DECREASED 190 0.0169
106 PLEURITIC PAIN 46 0.0166
107 SENSATION OF FOREIGN BODY 139 0.0165
108 MYASTHENIA GRAVIS 129 0.0160
109 HYPOPHOSPHATAEMIA 117 0.0158
110 ORAL CANDIDIASIS 208 0.0158
111 NAIL DISCOLOURATION 61 0.0155
112 APPLICATION SITE DISCOLOURATION 63 0.0155
113 RESPIRATORY SYMPTOM 44 0.0155
114 REBOUND ACID HYPERSECRETION 46 0.0152
115 NEPHROGENIC SYSTEMIC FIBROSIS 45 0.0149
116 SPINAL STENOSIS 61 0.0148
117 MEAN CELL VOLUME INCREASED 36 0.0140
118 AORTIC ARTERIOSCLEROSIS 36 0.0140
119 ACTINIC KERATOSIS 36 0.0139
120 SWELLING OF EYELID 87 0.0138
121 BENIGN PROSTATIC HYPERPLASIA 71 0.0137
122 INCREASED UPPER AIRWAY SECRETION 70 0.0136
123 OBSTRUCTIVE AIRWAYS DISORDER 151 0.0136
124 PRODUCT RESIDUE PRESENT 73 0.0135
125 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 955 0.0134
126 SECRETION DISCHARGE 166 0.0132
127 BLOOD CALCIUM INCREASED 115 0.0131
128 PERIORBITAL SWELLING 72 0.0127
129 MICTURITION URGENCY 145 0.0127
130 TROPONIN INCREASED 96 0.0126
131 BLOOD PRESSURE DIASTOLIC ABNORMAL 32 0.0126
132 THERAPEUTIC RESPONSE UNEXPECTED 563 0.0125
133 APPENDICITIS 117 0.0125
134 SEASONAL ALLERGY 174 0.0123
135 ORTHOSTATIC HYPOTENSION 211 0.0121
136 VITAMIN B12 DEFICIENCY 49 0.0121
137 SKIN TIGHTNESS 56 0.0119
138 APPLICATION SITE SWELLING 59 0.0118
139 PRODUCT PACKAGING ISSUE 110 0.0116
140 SPONDYLITIS 42 0.0115
141 SPINAL OSTEOARTHRITIS 101 0.0115
142 PRODUCT ADMINISTRATION INTERRUPTED 90 0.0115
143 INFUSION SITE PRURITUS 36 0.0114
144 THERAPEUTIC PRODUCT EFFECT DELAYED 52 0.0114
145 LOSS OF LIBIDO 101 0.0112
146 LEFT VENTRICULAR HYPERTROPHY 48 0.0112
147 BREATH SOUNDS ABNORMAL 55 0.0111
148 NAIL DISORDER 97 0.0111
149 SCAB 124 0.0109
150 INFUSION SITE SWELLING 68 0.0108
151 TRIGGER FINGER 44 0.0108
152 MULTIPLE ALLERGIES 84 0.0107
153 ERECTILE DYSFUNCTION 273 0.0106
154 HYPERLIPIDAEMIA 127 0.0106
155 CARBOHYDRATE ANTIGEN 125 INCREASED 36 0.0105
156 SEXUAL DYSFUNCTION 123 0.0105
157 VITAMIN D DEFICIENCY 102 0.0104
158 DERMATITIS CONTACT 117 0.0102
159 CONTRAINDICATED PRODUCT ADMINISTERED 310 0.0102
160 DECREASED INTEREST 60 0.0102
161 ROSACEA 47 0.0101
162 PROCEDURAL PAIN 279 0.0100
163 OSTEOPENIA 151 0.0099
164 VENTRICULAR FIBRILLATION 110 0.0099
165 NEURALGIA 239 0.0098
166 BLOOD POTASSIUM INCREASED 159 0.0098
167 EAR PRURITUS 34 0.0097
168 SKIN IRRITATION 431 0.0094
169 UPPER-AIRWAY COUGH SYNDROME 77 0.0093
170 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1680 0.0093
171 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 157 0.0091
172 INFUSION SITE ERYTHEMA 77 0.0091
173 VITAMIN D DECREASED 78 0.0091
174 FREQUENT BOWEL MOVEMENTS 241 0.0089
175 CYST 110 0.0089
176 DRUG EFFECT INCOMPLETE 321 0.0088
177 PNEUMOTHORAX 140 0.0088
178 SNORING 33 0.0087
179 PARANASAL SINUS DISCOMFORT 33 0.0087
180 BRAIN FOG 135 0.0086
181 SQUAMOUS CELL CARCINOMA OF SKIN 52 0.0086
182 BLOOD TEST ABNORMAL 121 0.0086
183 GOUT 154 0.0086
184 SLEEP APNOEA SYNDROME 162 0.0085
185 BACTERIAL INFECTION 158 0.0085
186 BLADDER DISORDER 84 0.0085
187 ULCER 134 0.0084
188 PERONEAL NERVE PALSY 47 0.0083
189 PERICARDIAL EFFUSION 191 0.0083
190 HORMONE LEVEL ABNORMAL 40 0.0082
191 BALANCE DISORDER 703 0.0081
192 SKIN DISORDER 271 0.0081
193 LARGE INTESTINE POLYP 56 0.0081
194 ONYCHOMYCOSIS 35 0.0080
195 CHRONIC KIDNEY DISEASE 606 0.0080
196 MENISCUS INJURY 49 0.0080
197 DRUG INEFFECTIVE 10493 0.0080
198 FUNGAL SKIN INFECTION 32 0.0079
199 DYSPNOEA EXERTIONAL 298 0.0079
200 EOSINOPHILIA 138 0.0079
201 INCREASED TENDENCY TO BRUISE 72 0.0078
202 OVERDOSE 1685 0.0078
203 LIGAMENT SPRAIN 77 0.0078
204 CARDIAC TAMPONADE 37 0.0078
205 AORTIC VALVE INCOMPETENCE 33 0.0077
206 CONCUSSION 60 0.0077
207 URINE ABNORMALITY 35 0.0077
208 EYE PAIN 434 0.0077
209 CARDIOGENIC SHOCK 110 0.0077
210 PAIN OF SKIN 206 0.0076
211 NOCTURIA 92 0.0076
212 COGNITIVE DISORDER 353 0.0076
213 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1520 0.0075
214 FULL BLOOD COUNT ABNORMAL 79 0.0075
215 DRY EYE 371 0.0074
216 RENAL CYST 59 0.0074
217 SKIN EXFOLIATION 626 0.0074
218 INCORRECT DOSE ADMINISTERED 1688 0.0074
219 OSTEOARTHRITIS 313 0.0074
220 PRODUCT LABEL ISSUE 50 0.0074
221 PRODUCT USE ISSUE 1382 0.0073
222 NASAL DRYNESS 46 0.0073
223 EYE SWELLING 273 0.0073
224 DIVERTICULUM INTESTINAL 32 0.0073
225 PRODUCT USE IN UNAPPROVED INDICATION 1809 0.0073
226 MELANOCYTIC NAEVUS 32 0.0073
227 LYMPHOCYTE COUNT DECREASED 129 0.0073
228 CONSTIPATION 1575 0.0072
229 FOREIGN BODY SENSATION IN EYES 46 0.0072
230 BODY HEIGHT DECREASED 77 0.0072
231 CORONARY ARTERY DISEASE 218 0.0072
232 UNDERDOSE 525 0.0072
233 SEDATION 188 0.0072
234 VARICOSE VEIN 37 0.0072
235 JOINT INJURY 153 0.0072
236 PALPITATIONS 838 0.0071
237 PAPULE 50 0.0071
238 ASTHENOPIA 39 0.0071
239 HYPERKERATOSIS 39 0.0071
240 INFUSION SITE PAIN 91 0.0071
241 BLOOD THYROID STIMULATING HORMONE DECREASED 32 0.0070
242 PHOTOPHOBIA 132 0.0070
243 BLOOD IRON DECREASED 83 0.0070
244 SKIN ABRASION 33 0.0070
245 EYE IRRITATION 400 0.0069
246 HYPERCHOLESTEROLAEMIA 67 0.0069
247 RESTLESS LEGS SYNDROME 126 0.0069
248 BLOOD CHOLESTEROL ABNORMAL 32 0.0069
249 ANAL INCONTINENCE 62 0.0069
250 HIATUS HERNIA 89 0.0069
251 UPPER RESPIRATORY TRACT INFECTION 316 0.0068
252 EYE INFECTION 77 0.0068
253 VITREOUS FLOATERS 67 0.0068
254 ARTHROPOD BITE 50 0.0067
255 PERIORBITAL OEDEMA 35 0.0067
256 EAR PAIN 131 0.0067
257 DYSPEPSIA 660 0.0067
258 DYSPHONIA 392 0.0067
259 MOBILITY DECREASED 481 0.0067
260 OCULAR DISCOMFORT 75 0.0067
261 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 475 0.0067
262 COLITIS 252 0.0066
263 INTENTIONAL PRODUCT MISUSE 581 0.0066
264 ROTATOR CUFF SYNDROME 85 0.0066
265 INTERVERTEBRAL DISC DEGENERATION 61 0.0066
266 SINUS DISORDER 130 0.0066
267 HYPERSENSITIVITY 1218 0.0066
268 CENTRAL NERVOUS SYSTEM LESION 90 0.0065
269 HEART RATE INCREASED 648 0.0065
270 SWELLING FACE 424 0.0065
271 DRUG EFFECT LESS THAN EXPECTED 96 0.0065
272 SINUSITIS 663 0.0065
273 INITIAL INSOMNIA 66 0.0064
274 EAR DISCOMFORT 66 0.0064
275 CARPAL TUNNEL SYNDROME 90 0.0064
276 GASTROOESOPHAGEAL REFLUX DISEASE 517 0.0064
277 SKIN LACERATION 69 0.0063
278 HYPERAESTHESIA 52 0.0063
279 HEAD DISCOMFORT 112 0.0063
280 HAEMORRHOIDS 123 0.0063
281 TEMPERATURE INTOLERANCE 65 0.0063
282 HEART RATE IRREGULAR 142 0.0063
283 SKIN ATROPHY 36 0.0062
284 DRY MOUTH 507 0.0062
285 SENSITIVE SKIN 46 0.0062
286 PRURITUS 2394 0.0062
287 ASPIRATION 68 0.0062
288 MADAROSIS 72 0.0062
289 HEADACHE 3871 0.0062
290 DRY SKIN 823 0.0062
291 FOOD POISONING 33 0.0062
292 BLOOD MAGNESIUM DECREASED 53 0.0061
293 BURNING SENSATION 429 0.0061
294 SLEEP DISORDER 430 0.0061
295 RECTAL HAEMORRHAGE 261 0.0061
296 WALKING AID USER 40 0.0061
297 THERMAL BURN 43 0.0061
298 SKIN LESION 166 0.0060
299 BLOOD ALBUMIN DECREASED 48 0.0060
300 MUSCLE SPASTICITY 74 0.0060
301 RED BLOOD CELL COUNT DECREASED 172 0.0060
302 MUSCLE STRAIN 52 0.0060
303 RASH PAPULAR 134 0.0060
304 SCIATICA 95 0.0060
305 ASCITES 175 0.0059
306 PRODUCT PHYSICAL ISSUE 120 0.0059
307 SKIN DISCOLOURATION 273 0.0059
308 INCORRECT PRODUCT ADMINISTRATION DURATION 128 0.0059
309 THYROID DISORDER 91 0.0059
310 LIMB DISCOMFORT 182 0.0059
311 BLOOD PRESSURE FLUCTUATION 141 0.0059
312 INFUSION RELATED REACTION 389 0.0059
313 BLOOD CHOLESTEROL INCREASED 273 0.0059
314 SKIN WARM 34 0.0058
315 BREAST MASS 39 0.0058
316 SPUTUM DISCOLOURED 55 0.0058
317 MIGRAINE 553 0.0058
318 BRONCHIECTASIS 39 0.0058
319 PERIPHERAL SWELLING 890 0.0058
320 EYE DISCHARGE 60 0.0058
321 ENERGY INCREASED 34 0.0058
322 ABDOMINAL DISTENSION 600 0.0057
323 VULVOVAGINAL BURNING SENSATION 35 0.0057
324 NECK PAIN 320 0.0057
325 MOUTH SWELLING 33 0.0057
326 INTERVERTEBRAL DISC PROTRUSION 125 0.0057
327 ERYTHEMA 1171 0.0057
328 GROIN PAIN 50 0.0057
329 TENDON PAIN 43 0.0057
330 CHEST DISCOMFORT 575 0.0056
331 COLITIS ULCERATIVE 250 0.0056
332 CARDIAC FLUTTER 36 0.0056
333 TENDERNESS 58 0.0056
334 HAEMATOCRIT DECREASED 109 0.0055
335 INSURANCE ISSUE 84 0.0055
336 DIVERTICULUM 39 0.0055
337 PRODUCT USE COMPLAINT 86 0.0055
338 DERMATITIS 114 0.0054
339 BLOOD PRESSURE SYSTOLIC INCREASED 106 0.0054
340 HYPOAESTHESIA 811 0.0054
341 SKIN SWELLING 47 0.0054
342 RESPIRATORY TRACT CONGESTION 86 0.0054
343 GLUCOSE TOLERANCE IMPAIRED 32 0.0054
344 POST PROCEDURAL INFECTION 44 0.0054
345 CEREBRAL DISORDER 40 0.0054
346 CONTUSION 519 0.0054
347 CONDITION AGGRAVATED 1636 0.0054
348 DRUG PRESCRIBING ERROR 103 0.0054
349 BOWEL MOVEMENT IRREGULARITY 41 0.0053
350 URINARY TRACT INFECTION 912 0.0053
351 DEPRESSED LEVEL OF CONSCIOUSNESS 211 0.0053
352 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151 0.0053
353 SINUS CONGESTION 72 0.0053
354 LACRIMATION INCREASED 161 0.0053
355 SCOLIOSIS 33 0.0053
356 SKIN REACTION 75 0.0053
357 POLLAKIURIA 222 0.0053
358 ORAL PAIN 119 0.0053
359 NERVE COMPRESSION 49 0.0053
360 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 255 0.0053
361 MUSCULOSKELETAL CHEST PAIN 82 0.0053
362 HOT FLUSH 399 0.0053
363 MULTIPLE SCLEROSIS 253 0.0053
364 CYSTITIS 168 0.0053
365 FLATULENCE 299 0.0053
366 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 289 0.0053
367 MUSCLE SPASMS 959 0.0052
368 THERAPEUTIC PRODUCT EFFECT DECREASED 234 0.0052
369 ATAXIA 62 0.0052
370 BLOOD COUNT ABNORMAL 79 0.0052
371 IRON DEFICIENCY ANAEMIA 48 0.0052
372 MIDDLE INSOMNIA 97 0.0052
373 SOMNAMBULISM 34 0.0052
374 FACIAL PARALYSIS 44 0.0052
375 PRODUCT QUALITY ISSUE 701 0.0052
376 GASTROENTERITIS VIRAL 93 0.0051
377 ATRIAL FLUTTER 41 0.0051
378 ORAL HERPES 100 0.0051
379 FULL BLOOD COUNT DECREASED 103 0.0051
380 PULMONARY MASS 76 0.0051
381 FUNGAL INFECTION 170 0.0051
382 DIZZINESS 2541 0.0051
383 OROPHARYNGEAL DISCOMFORT 46 0.0051
384 PARAESTHESIA 800 0.0051
385 SKIN INFECTION 57 0.0051
386 BLOOD PRESSURE ABNORMAL 101 0.0051
387 WEIGHT FLUCTUATION 53 0.0051
388 SKIN FISSURES 99 0.0051
389 PHOTOPSIA 32 0.0051
390 FIBROMYALGIA 123 0.0051
391 BLOOD POTASSIUM DECREASED 152 0.0051
392 DRUG ADMINISTRATION ERROR 155 0.0050
393 MUSCULOSKELETAL STIFFNESS 442 0.0050
394 RASH PRURITIC 273 0.0050
395 DRY THROAT 51 0.0050
396 ERUCTATION 97 0.0050
397 BASAL CELL CARCINOMA 78 0.0050
398 JOINT STIFFNESS 131 0.0050
399 BLOOD PRESSURE INCREASED 762 0.0050
400 WEIGHT INCREASED 1116 0.0050
401 BLOOD TESTOSTERONE DECREASED 34 0.0050
402 FOOT DEFORMITY 55 0.0050
403 URINARY INCONTINENCE 147 0.0050
404 MULTIPLE SCLEROSIS RELAPSE 340 0.0050
405 MUSCULOSKELETAL DISCOMFORT 85 0.0049
406 MUSCULAR WEAKNESS 561 0.0049
407 FACIAL PAIN 44 0.0049
408 PRODUCTIVE COUGH 235 0.0049
409 FLUSHING 500 0.0049
410 DECREASED ACTIVITY 53 0.0049
411 DECUBITUS ULCER 40 0.0049
412 SCAR 84 0.0049
413 BRONCHOSPASM 70 0.0049
414 FORMICATION 34 0.0049
415 RENAL INJURY 145 0.0049
416 MUSCLE TIGHTNESS 79 0.0049
417 SKIN BURNING SENSATION 349 0.0049
418 SPINAL OPERATION 60 0.0049
419 ATRIAL FIBRILLATION 473 0.0049
420 EAR INFECTION 129 0.0048
421 JOINT RANGE OF MOTION DECREASED 65 0.0048
422 FEELING DRUNK 36 0.0048
423 SWELLING 453 0.0048
424 TASTE DISORDER 98 0.0048
425 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
426 NODULE 63 0.0048
427 RHINORRHOEA 312 0.0048
428 CHEST PAIN 894 0.0048
429 DEFORMITY 45 0.0048
430 RENAL FAILURE CHRONIC 37 0.0048
431 OCULAR HYPERAEMIA 228 0.0048
432 PNEUMONIA ASPIRATION 120 0.0048
433 IMPAIRED QUALITY OF LIFE 69 0.0048
434 KNEE OPERATION 47 0.0048
435 APHTHOUS ULCER 37 0.0048
436 HAEMATOCHEZIA 263 0.0048
437 WEIGHT DECREASED 1330 0.0048
438 NASOPHARYNGITIS 878 0.0048
439 ACNE 361 0.0048
440 OFF LABEL USE 4166 0.0048
441 OROPHARYNGEAL PAIN 440 0.0047
442 FATIGUE 3698 0.0047
443 RASH MACULAR 166 0.0047
444 DIZZINESS POSTURAL 46 0.0047
445 SCRATCH 50 0.0047
446 DEPRESSED MOOD 250 0.0047
447 VERTIGO 288 0.0047
448 THROAT IRRITATION 212 0.0047
449 ANKLE FRACTURE 73 0.0047
450 AFFECTIVE DISORDER 37 0.0047
451 PRODUCT ADMINISTRATION ERROR 95 0.0047
452 BURSITIS 57 0.0047
453 HYPOTHYROIDISM 150 0.0047
454 POOR QUALITY SLEEP 101 0.0047
455 GASTROINTESTINAL INFECTION 42 0.0047
456 DEPRESSION 1066 0.0047
457 CANDIDA INFECTION 79 0.0047
458 VISION BLURRED 642 0.0047
459 ARTERIOSCLEROSIS 44 0.0047
460 FAECES SOFT 34 0.0047
461 SENSORY DISTURBANCE 75 0.0047
462 LOCALISED INFECTION 113 0.0047
463 HEPATIC STEATOSIS 87 0.0047
464 THINKING ABNORMAL 87 0.0047
465 WHEEZING 276 0.0046
466 NASAL CONGESTION 273 0.0046
467 FALL 1543 0.0046
468 NIGHT SWEATS 149 0.0046
469 BRONCHITIS 342 0.0046
470 BLOOD SODIUM DECREASED 87 0.0046
471 BACK DISORDER 75 0.0046
472 BREAST PAIN 49 0.0046
473 GAIT DISTURBANCE 879 0.0046
474 HYPOAESTHESIA ORAL 69 0.0046
475 TINNITUS 210 0.0046
476 INSOMNIA 1212 0.0045
477 COUGH 1271 0.0045
478 RASH 1975 0.0045
479 FLUID RETENTION 230 0.0045
480 LOW DENSITY LIPOPROTEIN INCREASED 35 0.0045
481 PAIN IN JAW 128 0.0045
482 BREAST TENDERNESS 34 0.0045
483 UTERINE LEIOMYOMA 33 0.0045
484 DIVERTICULITIS 125 0.0045
485 WRIST FRACTURE 54 0.0045
486 MUSCLE ATROPHY 57 0.0045
487 FEELING COLD 125 0.0045
488 AGEUSIA 112 0.0045
489 INTENTIONAL DOSE OMISSION 128 0.0045
490 BLOOD CREATININE INCREASED 293 0.0045
491 IMPAIRED GASTRIC EMPTYING 61 0.0045
492 BACK PAIN 1036 0.0045
493 COVID-19 782 0.0045
494 BLISTER 250 0.0044
495 ADVERSE REACTION 59 0.0044
496 WHITE BLOOD CELL COUNT DECREASED 482 0.0044
497 OEDEMA PERIPHERAL 542 0.0044
498 TOOTH FRACTURE 49 0.0044
499 PRESYNCOPE 108 0.0044
500 MASS 62 0.0044
501 DENTAL CARIES 49 0.0044
502 FEELING HOT 271 0.0044
503 STOMATITIS 268 0.0044
504 SOMNOLENCE 889 0.0044
505 NASAL DISCOMFORT 35 0.0044
506 ARTHRITIS 347 0.0044
507 PRURITUS GENERALISED 95 0.0044
508 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 229 0.0044
509 MALNUTRITION 49 0.0044
510 NEUROPATHY PERIPHERAL 415 0.0044
511 GASTROINTESTINAL PAIN 48 0.0044
512 MEMORY IMPAIRMENT 599 0.0044
513 SPINAL COMPRESSION FRACTURE 36 0.0043
514 URINE OUTPUT DECREASED 38 0.0043
515 CELLULITIS 219 0.0043
516 EYE PRURITUS 146 0.0043
517 RESPIRATORY TRACT INFECTION 113 0.0043
518 IRRITABLE BOWEL SYNDROME 93 0.0043
519 FAECES DISCOLOURED 94 0.0043
520 HEAD INJURY 137 0.0043
521 FOOT FRACTURE 82 0.0043
522 NEPHROLITHIASIS 198 0.0043
523 RETCHING 92 0.0043
524 HYPERTENSIVE CRISIS 48 0.0043
525 GAIT INABILITY 144 0.0043
526 FEELING JITTERY 82 0.0043
527 EYE INFLAMMATION 41 0.0043
528 PLATELET COUNT INCREASED 56 0.0043
529 PRODUCT DOSE OMISSION IN ERROR 121 0.0043
530 GINGIVAL PAIN 34 0.0043
531 UPPER LIMB FRACTURE 85 0.0043
532 DYSURIA 157 0.0043
533 PAIN IN EXTREMITY 1256 0.0043
534 BONE PAIN 249 0.0042
535 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37 0.0042
536 PELVIC FRACTURE 33 0.0042
537 HYPERTENSION 894 0.0042
538 TENDON RUPTURE 52 0.0042
539 DIPLOPIA 109 0.0042
540 SKIN HAEMORRHAGE 62 0.0042
541 SPINAL PAIN 49 0.0042
542 NEPHROPATHY 39 0.0042
543 PANIC ATTACK 152 0.0042
544 ARTHRALGIA 1733 0.0042
545 JOINT SWELLING 503 0.0042
546 POST PROCEDURAL COMPLICATION 80 0.0042
547 APHONIA 58 0.0042
548 GASTROINTESTINAL DISORDER 372 0.0041
549 THERAPY CESSATION 213 0.0041
550 FEELING ABNORMAL 994 0.0041
551 ABDOMINAL PAIN 964 0.0041
552 ANAEMIA 790 0.0041
553 VENTRICULAR EXTRASYSTOLES 43 0.0041
554 ATRIOVENTRICULAR BLOCK 32 0.0041
555 TENDONITIS 64 0.0041
556 PLEURAL EFFUSION 251 0.0041
557 PHOTOSENSITIVITY REACTION 68 0.0041
558 ANXIETY 1169 0.0041
559 ILLNESS 423 0.0041
560 GLAUCOMA 79 0.0041
561 SENSORY LOSS 33 0.0041
562 IMMUNODEFICIENCY 61 0.0041
563 GRIP STRENGTH DECREASED 36 0.0041
564 THIRST 73 0.0041
565 ACCIDENTAL EXPOSURE TO PRODUCT 421 0.0041
566 MUSCULOSKELETAL PAIN 214 0.0041
567 INCREASED APPETITE 78 0.0041
568 PULMONARY HYPERTENSION 85 0.0041
569 DYSGEUSIA 303 0.0041
570 SURGERY 239 0.0041
571 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 69 0.0041
572 RENAL PAIN 43 0.0041
573 FLUID OVERLOAD 59 0.0040
574 FLANK PAIN 38 0.0040
575 LIVER FUNCTION TEST INCREASED 87 0.0040
576 CARDIAC DISORDER 379 0.0040
577 PAIN 2484 0.0040
578 HIP FRACTURE 130 0.0040
579 HYSTERECTOMY 35 0.0040
580 RENAL FAILURE 535 0.0040
581 PETECHIAE 42 0.0040
582 SLUGGISHNESS 41 0.0040
583 WHITE BLOOD CELL COUNT INCREASED 154 0.0040
584 LIMB INJURY 109 0.0040
585 HYPERSOMNIA 115 0.0040
586 PERIPHERAL COLDNESS 55 0.0040
587 NEUTROPHIL COUNT INCREASED 41 0.0040
588 MUSCLE TWITCHING 92 0.0040
589 THROMBOSIS 321 0.0040
590 RIB FRACTURE 82 0.0040
591 NAUSEA 3141 0.0040
592 THERAPY CHANGE 39 0.0040
593 FRUSTRATION TOLERANCE DECREASED 32 0.0040
594 NERVE INJURY 44 0.0040
595 EPISTAXIS 296 0.0040
596 SKIN HYPERPIGMENTATION 34 0.0040
597 QUALITY OF LIFE DECREASED 53 0.0039
598 HYPONATRAEMIA 222 0.0039
599 ECZEMA 206 0.0039
600 KIDNEY INFECTION 77 0.0039
601 BLOOD THYROID STIMULATING HORMONE INCREASED 36 0.0039
602 OEDEMA 212 0.0039
603 SPINAL DISORDER 37 0.0039
604 PRODUCT DISTRIBUTION ISSUE 36 0.0039
605 IMPAIRED DRIVING ABILITY 44 0.0039
606 IMMUNE SYSTEM DISORDER 51 0.0039
607 TOOTH DISORDER 86 0.0039
608 DISTURBANCE IN ATTENTION 208 0.0039
609 BLOOD URINE PRESENT 73 0.0038
610 OSTEOPOROSIS 158 0.0038
611 ATELECTASIS 37 0.0038
612 CATARACT 228 0.0038
613 SMALL INTESTINAL OBSTRUCTION 47 0.0038
614 ABDOMINAL DISCOMFORT 640 0.0038
615 WRONG DRUG ADMINISTERED 34 0.0038
616 TREMOR 633 0.0038
617 TOOTHACHE 69 0.0038
618 UROSEPSIS 35 0.0038
619 HYPOKINESIA 55 0.0038
620 PHARYNGEAL SWELLING 37 0.0038
621 APHASIA 114 0.0038
622 SUPRAVENTRICULAR TACHYCARDIA 36 0.0038
623 HERPES ZOSTER 216 0.0038
624 CLOSTRIDIUM DIFFICILE INFECTION 82 0.0038
625 BLOOD PRESSURE DECREASED 248 0.0037
626 TOOTH ABSCESS 38 0.0037
627 PSEUDOMONAS INFECTION 32 0.0037
628 DIARRHOEA 2406 0.0037
629 SPEECH DISORDER 195 0.0037
630 CHILLS 436 0.0037
631 TOOTH INFECTION 49 0.0037
632 ASTHENIA 1395 0.0037
633 TRANSIENT ISCHAEMIC ATTACK 125 0.0037
634 BLOOD UREA INCREASED 62 0.0037
635 MYALGIA 629 0.0037
636 HYPOTENSION 741 0.0037
637 LIP SWELLING 123 0.0037
638 URTICARIA 616 0.0037
639 VIRAL INFECTION 122 0.0037
640 DYSPNOEA 2075 0.0037
641 HAEMOGLOBIN DECREASED 376 0.0037
642 BODY TEMPERATURE DECREASED 36 0.0037
643 ARTHROPATHY 203 0.0036
644 FEAR 98 0.0036
645 EYELID PTOSIS 37 0.0036
646 HEREDITARY ANGIOEDEMA 39 0.0036
647 RESTLESSNESS 133 0.0036
648 COLD SWEAT 64 0.0036
649 PRODUCT ODOUR ABNORMAL 38 0.0036
650 PHARYNGITIS 45 0.0036
651 INTENTIONAL PRODUCT USE ISSUE 317 0.0036
652 EATING DISORDER 77 0.0036
653 MOVEMENT DISORDER 116 0.0036
654 HEMIPARESIS 61 0.0036
655 DECREASED APPETITE 835 0.0036
656 HYPERTHYROIDISM 52 0.0036
657 MENTAL IMPAIRMENT 87 0.0036
658 INFLUENZA 400 0.0036
659 ACUTE RESPIRATORY FAILURE 69 0.0036
660 BACK INJURY 39 0.0036
661 SPLENOMEGALY 42 0.0036
662 MALIGNANT MELANOMA 48 0.0036
663 LYMPHADENOPATHY 126 0.0036
664 SARS-COV-2 TEST POSITIVE 47 0.0036
665 CONJUNCTIVITIS 66 0.0036
666 ABDOMINAL PAIN UPPER 732 0.0036
667 PRODUCT DOSE OMISSION ISSUE 1038 0.0035
668 FOLLICULITIS 37 0.0035
669 EYE DISORDER 116 0.0035
670 DYSSTASIA 103 0.0035
671 SKIN ULCER 91 0.0035
672 MUSCULOSKELETAL DISORDER 67 0.0035
673 HERNIA 68 0.0035
674 DRUG EFFECT DECREASED 189 0.0035
675 IMPAIRED WORK ABILITY 75 0.0035
676 VISUAL IMPAIRMENT 433 0.0035
677 AUTOIMMUNE DISORDER 34 0.0035
678 PNEUMONIA BACTERIAL 32 0.0035
679 POOR VENOUS ACCESS 36 0.0035
680 GENERALISED OEDEMA 43 0.0035
681 COVID-19 PNEUMONIA 41 0.0035
682 INJECTION SITE URTICARIA 85 0.0035
683 TOOTH EXTRACTION 43 0.0035
684 EYELID OEDEMA 40 0.0034
685 PRODUCT SUBSTITUTION ISSUE 198 0.0034
686 PHARYNGITIS STREPTOCOCCAL 37 0.0034
687 DIABETES MELLITUS 260 0.0034
688 NERVOUSNESS 178 0.0034
689 DRUG INTOLERANCE 329 0.0034
690 INCONTINENCE 36 0.0034
691 OVARIAN CYST 34 0.0034
692 EXPOSURE VIA SKIN CONTACT 88 0.0034
693 INJECTION SITE PRURITUS 227 0.0034
694 RASH ERYTHEMATOUS 162 0.0034
695 LOWER LIMB FRACTURE 65 0.0034
696 ORAL DISCOMFORT 47 0.0034
697 ASPARTATE AMINOTRANSFERASE INCREASED 179 0.0034
698 DISCOMFORT 205 0.0034
699 CRYING 122 0.0034
700 DYSARTHRIA 126 0.0033
701 SKIN CANCER 72 0.0033
702 DYSMENORRHOEA 44 0.0033
703 NEOPLASM 38 0.0033
704 CLOSTRIDIUM DIFFICILE COLITIS 35 0.0033
705 HAEMOPTYSIS 92 0.0033
706 BONE DISORDER 60 0.0033
707 INFECTION 476 0.0033
708 INTRAOCULAR PRESSURE INCREASED 42 0.0033
709 CHROMATURIA 74 0.0033
710 ACUTE KIDNEY INJURY 501 0.0033
711 PRODUCT DOSE OMISSION 213 0.0033
712 GLOMERULAR FILTRATION RATE DECREASED 40 0.0033
713 HYPERCALCAEMIA 40 0.0032
714 HEPATIC ENZYME INCREASED 220 0.0032
715 MOOD ALTERED 88 0.0032
716 UNEVALUABLE EVENT 244 0.0032
717 OXYGEN SATURATION DECREASED 181 0.0032
718 BIPOLAR DISORDER 35 0.0032
719 PYREXIA 1112 0.0032
720 DEHYDRATION 428 0.0032
721 SPINAL FRACTURE 64 0.0032
722 HEART RATE DECREASED 112 0.0032
723 STAPHYLOCOCCAL INFECTION 105 0.0032
724 ACCIDENT 38 0.0032
725 LETHARGY 183 0.0032
726 CARDIOMEGALY 39 0.0032
727 HYPOPHAGIA 81 0.0032
728 SNEEZING 71 0.0032
729 HUNGER 44 0.0032
730 PRESCRIBED UNDERDOSE 63 0.0032
731 GASTRITIS 83 0.0032
732 APATHY 46 0.0032
733 PLATELET COUNT DECREASED 336 0.0031
734 AMNESIA 205 0.0031
735 GINGIVAL BLEEDING 43 0.0031
736 INJECTION SITE BRUISING 251 0.0031
737 TACHYCARDIA 279 0.0031
738 SWOLLEN TONGUE 98 0.0031
739 GALLBLADDER DISORDER 56 0.0031
740 IMPAIRED HEALING 103 0.0031
741 KNEE ARTHROPLASTY 66 0.0031
742 MALAISE 1374 0.0031
743 DEMENTIA 87 0.0031
744 CARDIAC FAILURE CONGESTIVE 250 0.0031
745 ROAD TRAFFIC ACCIDENT 130 0.0031
746 DIALYSIS 44 0.0031
747 RENAL DISORDER 144 0.0031
748 SEPSIS 344 0.0031
749 INTESTINAL OBSTRUCTION 116 0.0031
750 CHOKING 60 0.0031
751 PARALYSIS 44 0.0031
752 ASTHMA 346 0.0031
753 FEEDING DISORDER 62 0.0031
754 DEVICE RELATED INFECTION 47 0.0031
755 ANHEDONIA 80 0.0030
756 BEDRIDDEN 40 0.0030
757 MOOD SWINGS 97 0.0030
758 WOUND 85 0.0030
759 ANOSMIA 44 0.0030
760 ECONOMIC PROBLEM 46 0.0030
761 LOWER RESPIRATORY TRACT INFECTION 138 0.0030
762 INJECTION SITE RASH 93 0.0030
763 DISORIENTATION 120 0.0030
764 PRODUCT TASTE ABNORMAL 41 0.0030
765 DERMATITIS ALLERGIC 38 0.0030
766 OESOPHAGITIS 33 0.0030
767 GASTROENTERITIS 44 0.0030
768 WOUND INFECTION 33 0.0030
769 HYPERHIDROSIS 385 0.0030
770 LUNG DISORDER 146 0.0030
771 INFLUENZA LIKE ILLNESS 245 0.0030
772 SUICIDAL IDEATION 272 0.0030
773 ANGINA PECTORIS 85 0.0030
774 PULMONARY CONGESTION 39 0.0030
775 RENAL IMPAIRMENT 248 0.0029
776 INCORRECT DRUG ADMINISTRATION DURATION 83 0.0029
777 VOMITING 1387 0.0029
778 OBESITY 47 0.0029
779 PROTEINURIA 56 0.0029
780 PULMONARY THROMBOSIS 32 0.0029
781 PNEUMONIA 944 0.0029
782 INJECTION SITE ERYTHEMA 361 0.0029
783 FEMUR FRACTURE 90 0.0029
784 DYSPHAGIA 275 0.0029
785 RHEUMATOID ARTHRITIS 328 0.0029
786 PULMONARY EMBOLISM 273 0.0029
787 INFLAMMATION 148 0.0029
788 PULMONARY FIBROSIS 55 0.0029
789 ABDOMINAL PAIN LOWER 72 0.0028
790 LABORATORY TEST ABNORMAL 84 0.0028
791 NEUTROPHIL COUNT DECREASED 116 0.0028
792 GASTRIC ULCER 54 0.0028
793 ANGER 96 0.0028
794 BLOOD TRIGLYCERIDES INCREASED 50 0.0028
795 THERAPY INTERRUPTED 202 0.0028
796 DERMATITIS ATOPIC 149 0.0028
797 EMOTIONAL DISORDER 87 0.0028
798 HYPOXIA 99 0.0028
799 INJECTION SITE DISCOLOURATION 35 0.0028
800 INJECTION SITE SWELLING 213 0.0028
801 RESPIRATORY DISORDER 83 0.0028
802 GLOSSODYNIA 62 0.0028
803 PULMONARY OEDEMA 124 0.0028
804 HYPOACUSIS 119 0.0028
805 THERAPEUTIC RESPONSE DECREASED 167 0.0028
806 DEAFNESS 72 0.0028
807 PELVIC PAIN 50 0.0027
808 PSORIASIS 359 0.0027
809 LOSS OF CONSCIOUSNESS 352 0.0027
810 ACUTE MYOCARDIAL INFARCTION 81 0.0027
811 TRANSAMINASES INCREASED 61 0.0027
812 PRESCRIBED OVERDOSE 53 0.0027
813 ALANINE AMINOTRANSFERASE INCREASED 168 0.0027
814 INJECTION SITE MASS 101 0.0027
815 PRODUCT PREPARATION ERROR 56 0.0027
816 LIVER DISORDER 120 0.0027
817 MOUTH ULCERATION 57 0.0027
818 VAGINAL HAEMORRHAGE 117 0.0027
819 THERAPEUTIC RESPONSE SHORTENED 89 0.0027
820 GENERAL PHYSICAL HEALTH DETERIORATION 310 0.0027
821 BLOOD ALKALINE PHOSPHATASE INCREASED 66 0.0027
822 SYNCOPE 265 0.0026
823 CARDIOMYOPATHY 39 0.0026
824 LOCAL SWELLING 46 0.0026
825 PSORIATIC ARTHROPATHY 107 0.0026
826 IRRITABILITY 158 0.0026
827 GLYCOSYLATED HAEMOGLOBIN INCREASED 66 0.0026
828 CARDIOVASCULAR DISORDER 66 0.0026
829 CHOLELITHIASIS 85 0.0026
830 THROAT TIGHTNESS 70 0.0026
831 DYSKINESIA 105 0.0026
832 ACTIVITIES OF DAILY LIVING IMPAIRED 51 0.0026
833 TUBULOINTERSTITIAL NEPHRITIS 48 0.0026
834 HAEMATOMA 66 0.0025
835 INJECTION SITE INDURATION 33 0.0025
836 ARRHYTHMIA 120 0.0025
837 PRODUCT COMPLAINT 64 0.0025
838 DELUSION 39 0.0025
839 HYPERKALAEMIA 88 0.0025
840 GASTRIC DISORDER 86 0.0025
841 FACE OEDEMA 42 0.0025
842 NIGHTMARE 86 0.0025
843 HIP ARTHROPLASTY 38 0.0025
844 CORONARY ARTERY OCCLUSION 34 0.0025
845 SEIZURE 286 0.0025
846 ADVERSE EVENT 226 0.0024
847 EJECTION FRACTION DECREASED 38 0.0024
848 PRODUCT PRESCRIBING ERROR 58 0.0024
849 BODY TEMPERATURE INCREASED 49 0.0024
850 EYE HAEMORRHAGE 32 0.0024
851 URINARY RETENTION 80 0.0024
852 INJECTION SITE WARMTH 49 0.0024
853 TYPE 2 DIABETES MELLITUS 80 0.0024
854 PHARYNGEAL OEDEMA 36 0.0023
855 BLINDNESS UNILATERAL 33 0.0023
856 SYSTEMIC LUPUS ERYTHEMATOSUS 83 0.0023
857 SINUS TACHYCARDIA 33 0.0023
858 OSTEOMYELITIS 42 0.0023
859 BRADYCARDIA 123 0.0023
860 CONFUSIONAL STATE 374 0.0023
861 ABNORMAL DREAMS 63 0.0023
862 PULMONARY ARTERIAL HYPERTENSION 33 0.0023
863 COMPLICATION ASSOCIATED WITH DEVICE 33 0.0023
864 DISEASE RECURRENCE 108 0.0023
865 WITHDRAWAL SYNDROME 94 0.0022
866 MENTAL STATUS CHANGES 62 0.0022
867 INJECTION SITE PAIN 682 0.0022
868 EXTRA DOSE ADMINISTERED 90 0.0022
869 LEUKOCYTOSIS 40 0.0022
870 DRUG DOSE OMISSION 365 0.0022
871 THERAPY NON-RESPONDER 99 0.0022
872 HALLUCINATION 163 0.0022
873 PARANOIA 37 0.0021
874 BLINDNESS 87 0.0021
875 NEOPLASM PROGRESSION 74 0.0021
876 THERAPY PARTIAL RESPONDER 33 0.0021
877 MENORRHAGIA 41 0.0021
878 CEREBRAL INFARCTION 51 0.0021
879 HALLUCINATION, VISUAL 44 0.0021
880 BLOOD BILIRUBIN INCREASED 56 0.0021
881 INJECTION SITE REACTION 142 0.0021
882 C-REACTIVE PROTEIN INCREASED 75 0.0021
883 BLOOD GLUCOSE ABNORMAL 38 0.0021
884 HAEMORRHAGE 215 0.0021
885 HYPERGLYCAEMIA 74 0.0020
886 MENTAL DISORDER 88 0.0020
887 PRODUCT AVAILABILITY ISSUE 46 0.0020
888 BLOOD GLUCOSE DECREASED 97 0.0020
889 HAEMATURIA 69 0.0020
890 ACCIDENTAL OVERDOSE 73 0.0020
891 ABASIA 49 0.0020
892 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 46 0.0020
893 AGITATION 144 0.0020
894 DRUG INTERACTION 311 0.0020
895 HYPOKALAEMIA 90 0.0019
896 DEVICE USE ISSUE 34 0.0019
897 GASTROINTESTINAL HAEMORRHAGE 161 0.0019
898 TREATMENT NONCOMPLIANCE 104 0.0019
899 DISEASE PROGRESSION 221 0.0019
900 INJURY 131 0.0019
901 NEEDLE ISSUE 54 0.0019
902 RASH GENERALISED 48 0.0019
903 HYPOCALCAEMIA 35 0.0018
904 RESPIRATORY DISTRESS 51 0.0018
905 HOSPITALISATION 282 0.0018
906 DISABILITY 36 0.0018
907 PALLOR 49 0.0018
908 DEEP VEIN THROMBOSIS 115 0.0018
909 FEBRILE NEUTROPENIA 117 0.0018
910 PANCREATITIS 93 0.0018
911 BLOOD GLUCOSE INCREASED 330 0.0017
912 VISUAL ACUITY REDUCED 58 0.0017
913 TREATMENT FAILURE 144 0.0017
914 PRODUCT STORAGE ERROR 152 0.0017
915 COMA 82 0.0017
916 METABOLIC ACIDOSIS 54 0.0017
917 CEREBRAL HAEMORRHAGE 60 0.0017
918 UNRESPONSIVE TO STIMULI 43 0.0017
919 TARDIVE DYSKINESIA 47 0.0017
920 NEOPLASM MALIGNANT 111 0.0017
921 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
922 RESPIRATORY FAILURE 121 0.0017
923 INJECTION SITE HAEMORRHAGE 132 0.0017
924 DEVICE ISSUE 148 0.0016
925 CEREBROVASCULAR ACCIDENT 275 0.0016
926 MYOCARDIAL INFARCTION 282 0.0016
927 MENSTRUATION IRREGULAR 43 0.0016
928 PNEUMONITIS 43 0.0016
929 INTERNATIONAL NORMALISED RATIO INCREASED 45 0.0016
930 NERVOUS SYSTEM DISORDER 49 0.0016
931 ILL-DEFINED DISORDER 95 0.0016
932 PRODUCT DISPENSING ERROR 34 0.0016
933 JAUNDICE 42 0.0016
934 PANCREATITIS ACUTE 35 0.0016
935 PANCYTOPENIA 86 0.0015
936 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 45 0.0015
937 TOXICITY TO VARIOUS AGENTS 258 0.0015
938 PLASMA CELL MYELOMA 59 0.0015
939 PRODUCT ADHESION ISSUE 54 0.0015
940 HYPOGLYCAEMIA 73 0.0015
941 EMOTIONAL DISTRESS 182 0.0015
942 HAEMATEMESIS 38 0.0015
943 DIABETIC KETOACIDOSIS 36 0.0015
944 ANGIOEDEMA 66 0.0015
945 PSYCHOTIC DISORDER 44 0.0015
946 RENAL FAILURE ACUTE 63 0.0015
947 DEVICE DISLOCATION 64 0.0015
948 DELIRIUM 51 0.0015
949 BREAST CANCER FEMALE 39 0.0015
950 AGGRESSION 73 0.0015
951 NO ADVERSE EVENT 256 0.0014
952 LEUKOPENIA 70 0.0014
953 HEPATIC FUNCTION ABNORMAL 52 0.0014
954 SEPTIC SHOCK 59 0.0014
955 DEVICE MALFUNCTION 95 0.0014
956 THROMBOCYTOPENIA 149 0.0013
957 HEPATITIS 34 0.0013
958 CARDIO-RESPIRATORY ARREST 55 0.0013
959 MEDICATION ERROR 73 0.0013
960 ABNORMAL BEHAVIOUR 52 0.0013
961 CARDIAC FAILURE 105 0.0013
962 ANAPHYLACTIC REACTION 72 0.0013
963 BREAST CANCER 120 0.0013
964 MALIGNANT NEOPLASM PROGRESSION 130 0.0013
965 EPILEPSY 38 0.0012
966 EXPOSURE DURING PREGNANCY 74 0.0012
967 NEUTROPENIA 159 0.0012
968 GYNAECOMASTIA 36 0.0012
969 WRONG TECHNIQUE IN DRUG USAGE PROCESS 42 0.0012
970 LIVER FUNCTION TEST ABNORMAL 33 0.0011
971 HEPATIC FAILURE 34 0.0011
972 DEVICE BREAKAGE 44 0.0011
973 ABORTION SPONTANEOUS 42 0.0010
974 DEVICE LEAKAGE 45 0.0010
975 CONVULSION 59 0.0010
976 CARDIAC ARREST 84 0.0010
977 MATERNAL EXPOSURE DURING PREGNANCY 85 0.0010
978 INTERSTITIAL LUNG DISEASE 43 0.0009
979 DRUG ABUSE 72 0.0009
980 LUNG NEOPLASM MALIGNANT 35 0.0009
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 39 0.0008
982 DEATH 719 0.0008
983 DRUG WITHDRAWAL SYNDROME 73 0.0008
984 RHABDOMYOLYSIS 34 0.0008
985 SUICIDE ATTEMPT 47 0.0008
986 DEVICE EXPULSION 47 0.0007
987 COMPLETED SUICIDE 60 0.0007
988 FOETAL EXPOSURE DURING PREGNANCY 56 0.0007
989 DRUG DEPENDENCE 35 0.0002